Cohen Klingenstein Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Cohen Klingenstein reduced its stake in Monsanto Company by 0.41% during the most recent quarter end. The investment management company now holds a total of 60,256 shares of Monsanto Company which is valued at $5,668,884 after selling 249 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Apr 18, 2016.Monsanto Company makes up approximately 1.04% of Cohen Klingenstein’s portfolio.

Monsanto Company closed down -0.03 points or -0.03% at $94.08 with 31,04,911 shares getting traded on Friday. Post opening the session at $93.91, the shares hit an intraday low of $93.194 and an intraday high of $94.54 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Other Hedge Funds, Including , Bristol John W Co Inc Ny reduced its stake in MON by selling 24,445 shares or 3.73% in the most recent quarter. The Hedge Fund company now holds 630,549 shares of MON which is valued at $59,322,050. Monsanto Company makes up approx 1.57% of Bristol John W Co Inc Ny’s portfolio.Wunderlich Securities reduced its stake in MON by selling 108 shares or 4.06% in the most recent quarter. The Hedge Fund company now holds 2,552 shares of MON which is valued at $225,520. Monsanto Company makes up approx 0.33% of Wunderlich Securities’s portfolio.

On the company’s financial health, Monsanto Company reported $2.42 EPS for the quarter, based on the information available during the earnings call on Apr 6, 2016. Analyst had a consensus estimate of $2.42. The company had revenue of $4532.00 million for the quarter, compared to analysts expectations of $4734.36 million. The company’s revenue was down -12.8 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.90 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Shares were Reiterated by Deutsche Bank on Apr 7, 2016 to “Buy” and Lowered the Price Target to $ 100 from a previous price target of $105 .Monsanto Company was Downgraded by Citigroup to ” Neutral” on Mar 14, 2016. Monsanto Company was Downgraded by Goldman to ” Sell” on Mar 4, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.